TRV GP II’s Jounce Therapeutics, Inc. Common Stock JNCE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | $1.34M | Sell |
|
|||||
|
2022
Q2 | $4.08M | Hold |
|
|||||
|
2022
Q1 | $9.15M | Sell |
|
|||||
|
2021
Q4 | $22.5M | Hold |
|
|||||
|
2021
Q3 | $20M | Sell |
|
|||||
|
2021
Q2 | $30.2M | Sell |
|
|||||
|
2021
Q1 | $66.8M | Sell |
|
|||||
|
2020
Q4 | $64.4M | Sell |
|
|||||
|
2020
Q3 | $83.5M | Hold |
|
|||||
|
2020
Q2 | $70.6M | Hold |
|
|||||
|
2020
Q1 | $48.6M | Hold |
|
|||||
|
2019
Q4 | $89.3M | Hold |
|
|||||
|
2019
Q3 | $34.1M | Hold |
|
|||||
|
2019
Q2 | $50.6M | Hold |
|
|||||
|
2019
Q1 | $63.4M | Hold |
|
|||||
|
2018
Q4 | $34.5M | Hold |
|
|||||
|
2018
Q3 | $66.5M | Hold |
|
|||||
|
2018
Q2 | $78.4M | Hold |
|
|||||
|
2018
Q1 | $229M | Hold |
|
|||||
|
2017
Q4 | $130M | Buy |
|